Retinal hyperspectral imaging system by Photon etc.

The IRIS retinal hyperspectral imaging system from Photon etc. (Montreal, QC, Canada) delivers noninvasive localization of biomolecules in the eye fundus to develop treatments for retinal diseases such as diabetic retinopathy and age-related macular degeneration (AMD). Based on a mydriatic retinal camera and the company's tunable laser source, the system allows high-definition retinal imaging at any wavelength from 420 to 1000 nm. An automatic spectral calibration setup enables spectral reproducibility, while an integrated photodiode provides temporal normalization of light intensity. Features include a sensitive CCD camera for high-definition imaging, an XYZ manual positioning system, illumination based on the company's patented Bragg grating filtering technology, and <1 nm wavelength selection from a supercontinuum source. More Biophotonics Products ----- PRESS RELEASE Photon etc. announces the launch of IRISTM, an innovative Retinal Hyperspectral Imaging system Montreal, QC – Targeting the emergent field of hyperspectral retinal imaging, Photon etc. is proud to launch IRISTM, a new device for non-invasive localization of biomolecules in the eye fundus. Based on a custom-made mydriatic retinal camera and Photon etc.’s Tunable Laser Source, IRISTM is a versatile instrument that allows high definition retinal imaging at any wavelength from 420 to 1000 nm. IRISTM is the ideal research tool to better understand and develop tomorrow’s treatments for retinal diseases, such as diabetic retinopathy and age-related macular degeneration. This product is sold for research purposes only. Particularly developed for ophthalmological studies, an automatic spectral calibration setup guarantees spectral reproducibility in time, while an integrated photodiode provides the temporal normalization of the light intensity. The instrument includes a sensitive CCD camera for high definition imaging and comes with a chin rest and XYZ manual positioning system. The supplied illumination is based on Photon etc’s patented Bragg grating filtering technology and allows for a rapid and accurate (< 1 nm) wavelength selection from a supercontinuum source. IRISTM allows the non-invasive localization of structures and biomolecules in the retina using their specific spectral signatures. In collaboration with the Glaucoma and Retina Research Group at the University of Waterloo/University Health Network, Photon etc. is developing a method to study retinal blood vessels and their blood oxygen saturation. With this innovative system, it is possible to localize any structure or biomolecule with spectral signatures and gather more information about eye disorders. About Photon etc. Photon etc offers state-of-the-art photonic and optical research instrumentation. Its patented spectral imaging and optical sensing technologies provide solutions for a wide variety of scientific and industrial applications. Photon etc. aims to provide each researcher, engineer and technician with access to the latest innovations in optical and photonic instrumentation. From material analysis to medical imaging, Photon etc’s expertise and spirit of innovation allow the exploration of uncharted territories. -----Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn Follow OptoIQ on your iPhone; download the free app here.Subscribe now to BioOptics World magazine; it's free!